Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults

Launched by SUN YAT-SEN UNIVERSITY · Apr 9, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at whether taking a combination of certain vitamins and nutrients can help lower high levels of homocysteine in the blood. Homocysteine is an amino acid, and having too much of it can be a risk factor for heart problems. The study will include Chinese adults who have homocysteine levels above 10 μmol/L. They will be giving participants supplements that include folic acid, vitamin B6, vitamin B12, and betaine, to see if these can effectively reduce homocysteine levels.

To be eligible for this study, participants must be between 18 and 65 years old and have homocysteine levels between 10 and 100 μmol/L. It's important that they haven't taken any supplements or medications that could lower their homocysteine for at least a month before joining the trial. The study is open to all genders, and participants will be required to sign a consent form agreeing to take part in the research. If you're interested in helping with this study, it could be a chance to contribute to understanding how to manage homocysteine levels better!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Aged 18 - 65 years;
• • 2. Concentration of plasma homocysteine is between 10 and 100 μmol/L;
• • 3. Free from any supplements or drugs that may decrease plasma homocysteine concentration for at least 1 month prior to the beginning of study;
• • 4. Willing to participate in the study and sign informed consent.
• Exclusion Criteria:
• • 1. Pregnant or lactating women;
• • 2. Allergic physique or allergic to our compound nutrients tablets;
• • 3. Complicated with severe diseases;
• • 4. Unable to conduct study procedures;
• • 5. Participating in any other intervention studies.